Overexpression of macrophage inhibitory cytokine-1 induces metastasis of human prostate cancer cells through the FAK–RhoA signaling pathway
Open Access
- 30 November 2009
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 29 (9) , 1293-1302
Abstract
An elevated level of macrophage inhibitory cytokine-1 (MIC-1) is reported in the sera of patients with metastatic prostate cancer compared with that of benign diseases and healthy adults. We investigated the mechanistic role of MIC-1 overexpression in the metastasis of prostate cancer cells. Our study showed a progressive increase in secretory MIC-1 production correlated with the increase in the metastatic potential of PC-3 and LNPCa prostate cancer metastatic variants. Further, the in vitro studies using ‘loss-’ and ‘gain’-of-function approaches showed that ectopic overexpression of MIC-1 (PC-3-MIC-1) and forced downregulation of MIC-1(PC-3M-siMIC-1) enhanced and reduced the motility and invasiveness of these cells, respectively. Supporting our in vitro observations, all the mice orthotopically implanted with PC-3-MIC-1 cells developed metastasis compared with none in the PC-3-vector group. Our results showed that MIC-1 overexpression was associated with apparent changes in actin organization. In addition, an enhanced phosphorylation of focal adhesion kinase (FAK) and guanosine-5′-triphosphate (GTP)-bound RhoA was also seen; however, no significant change was observed in total FAK and RhoA levels in the PC-3-MIC-1 cells. Altogether, our findings show that MIC-1 has a role in prostate cancer metastasis, in part, by promoting the motility of these cells. Activation of the FAK–RhoA signaling pathway is involved in MIC-1-mediated actin reorganization, and thus, leads to an increase in the motility of prostate cancer cells.Keywords
This publication has 35 references indexed in Scilit:
- Control of motile and invasive cell phenotypes by focal adhesion kinaseBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2004
- Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells.2003
- Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.2003
- Cloning and Characterization of a Novel Member of the Transforming Growth Factor-β/Bone Morphogenetic Protein FamilyJournal of Biological Chemistry, 1998
- Identification of a novel member of the TGF-beta superfamily highly expressed in human placentaGene, 1997
- MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamilyProceedings of the National Academy of Sciences, 1997
- PLAB, a novel placental bone morphogenetic proteinBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1997
- TGFβ in prostate cancer: A growth inhibitor that can enhance tumorigenicityThe Prostate, 1997
- The war on cancerThe Lancet, 1996
- METASTATIC BEHAVIOR OF HUMAN-TUMOR CELL-LINES GROWN IN THE NUDE-MOUSE1984